EUVIMEDOpdag EUVIMED
Übersichtsarbeit

A Recent Update on the Role of Estrogen and Progesterone in Alzheimer's Disease

S Suganya, Ben Sundra Ashok, Thekkuttuparambil Ananthanarayanan Ajith

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.70025 ↗

At a glance

Übersichtsarbeit in Cell Biochemistry and Function, 2024. Written by S Suganya and 2 co-authors. Institution: Department of Biochemistry, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India. Major MEDLINE topics: Alzheimer Disease, Estrogens, Progesterone. Cited 16 times so far (Crossref); 123 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Alzheimer's disease (AD), one of the most prevalent neurodegenerative disease responsible for 60%–80% dementia cases globally. The disease is more prevalent among elder females. Female reproductive hormones are found to be essential for cellular activities in brain. The physiological role of neurotrophins and sex hormones in hippocampal region during neurogenesis and neuron differentiation was studied as well. In addition to triggering cellular pathways, estrogen and progesterone carry out a number of biological processes that lead to neuroprotection. They might have an impact on learning and memory. One of estrogen's modest antioxidant properties is its direct scavenging of free radicals. The neurotrophic effect of estrogen and progesterone can be explained by their ability to rise the expression of the brain‐derived neurotrophic factor (BDNF) mRNA. Additionally, they have the ability to degrade beta‐amyloid and stop inflammation, apoptotic neuronal cell death, and tau protein phosphorylation. To enhance their neuroprotective action, various cross‐talking pathways in cells that are mediated by estrogen, progesterone, and BDNF receptors. This include signaling by mitogen‐activated protein kinase/extracellular regulated kinase, phosphatidylinositol 3‐kinase/protein kinase B, and phospholipase/protein kinase C. Clinical research to establish the significance of these substances are fragmented, despite publications claiming a lower prevalence of AD when medication is started before menopause. This review article emphasizes an update on the role of estrogen, and progesterone in AD.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseEstrogensProgesteroneHumansAnimalsBrain-Derived Neurotrophic FactorFemaleNeuroprotective AgentsSignal Transduction

Author keywords

Alzheimer's diseasebrain‐derived neurotrophic factorestrogenneuropeptidesneurosteroidsprogesteronesynaptic plasticitytauopathies

Substances

EstrogensProgesteroneBrain-Derived Neurotrophic FactorNeuroprotective Agents

Authors and institutions

  • Department of Biochemistry, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India.
  • Department of Biochemistry, Amala Institute of Medical Sciences, Thrissur, Kerala, India.
  • Amala Integrated Medical Research Department, Amala Institute of Medical Sciences, Thrissur, Kerala, India.

Cite

APA

Suganya, S., Ashok, B. S., & Ajith, T. A. (2024). A Recent Update on the Role of Estrogen and Progesterone in Alzheimer's Disease. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70025

Vancouver

Suganya S, Ashok BS, Ajith TA. A Recent Update on the Role of Estrogen and Progesterone in Alzheimer's Disease. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.70025

BibTeX
@article{Suganya2024,
  author = {Suganya, S and Ashok, Ben Sundra and Ajith, Thekkuttuparambil Ananthanarayanan},
  title = {A Recent Update on the Role of Estrogen and Progesterone in Alzheimer's Disease},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.70025}
}
Start for free →